SABIR QURAISHI: Open Payments
NPI 1427082841 · PEEBLES, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,067 in 115 payments from 21 companies in 2025. Trend: 2023 $1,779 · 2024 $2,028 · 2025 $2,067
Food & beverage: $1,823Education: $244
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $346 |
| Teva Pharmaceuticals USA, Inc. | 11 | $342 |
| Sumitomo Pharma America, Inc. | 19 | $287 |
| ABBVIE INC. | 19 | $209 |
| Bayer Healthcare Pharmaceuticals Inc. | 12 | $191 |
| Neurocrine BioSciences, Inc. | 18 | $188 |
| Novo Nordisk Inc | 5 | $93 |
| Merck Sharp & Dohme LLC | 3 | $68 |
| Lilly USA, LLC | 2 | $63 |
| Amgen Inc. | 3 | $46 |
Products named: GEMTESA, AIRSUPRA, Kerendia, INGREZZA, UBRELVY, AUSTEDO XR, VERQUVO, UZEDY.
Industry payments across OH — which companies pay providers there.
